lutetium lu 177 vipivotide tetraxetan,cabazitaxel
emcure,sanofi,novartis
['dance', 'crpc', 'cabazitaxel', 'congrat', 'therap ']
today at #asco22: #therap updates! lu-psma vs cabazitaxel in mcrpc. lu-psma (still) improves pfs w/ better toxicity profile. crossover complicates os assessment, but.. better os than excluded (2/2 pet discordance) but prospectively followed pts. congrats and team! 
Husband, father, PGY-2 radiation oncology resident @WashURadOnc. Interested in improving equity through public policy. Stats nerd (MS statistics). Tweets=mine